The impact of pre-existing aortic stenosis and mitral regurgitation on patients with acute myocardial infarction
The prevalence of left-sided valvular heart disease (VHD) increases with age, but data on the impact of pre-existing VHD in patients with acute myocardial infarction (AMI) are limited. We aimed to define the clinical characteristics and outcomes of AMI patients with pre-existing left VHD. The analysis is based on data from three merged national registries. The dataset included 47,436 patients admitted with AMI over a 5year period at all Cath Labs nationwide. Pre-existing VHD was diagnosed in 1,445 patients (3.0%), moderate-to-severe mitral regurgitation (MR) in 510 patients (35.3%), and moderate-to-severe aortic stenosis (AS) in 869 patients (60.1%). Patients with VHD had worse baseline characteristics, pre-existing coronary artery disease, more complicated in-hospital course with higher Killip class, lower left ventricular ejection fraction, and more comorbidities. Angiographically more frequent left main stenosis, TIMI flow 3 before PCI, less frequent stent implantation. Patients with pre-existing VHD had significantly higher 7-day (10.1% vs. 4.5%, p < 0.001), 30-day (16.0% vs. 7.0%, p < 0.001) and 1-year mortality (28.7 vs. 12.7%, p < 0.001) compared to patients without. Conclusions. Patients with pre-existing VHD and AMI are characterized by complicated in-hospital course with higher Killip class, lower ejection fraction, angiographically less severe stenosis, TIMI flow 3 prior to PCI, and less frequent stent implantation. This is a high-risk group with higher short - and long-term mortality and earlier intervention should be considered.
Authors
- Martin Hutyra (ORCID: https://orcid.org/0000-0003-2931-1286)
- Milan Hromádka (ORCID: https://orcid.org/0000-0001-7108-5441)
- Oana Ionita
- Marek Šramko (ORCID: https://orcid.org/0000-0002-1379-0086)
- Teodora Vichova (ORCID: https://orcid.org/0000-0001-8314-4621)
- Pavol Tomašov
- Jiří Jarkovský (ORCID: https://orcid.org/0000-0002-1400-0111)
- Jan Mrózek (ORCID: https://orcid.org/0000-0003-0674-5567)
- Petr Kala (ORCID: https://orcid.org/0000-0001-5626-7706)
- Zuzana Moťovská (ORCID: https://orcid.org/0000-0002-5319-473X)
- Tamilla Muzafarova
- Ota Hlinomaz (ORCID: https://orcid.org/0000-0002-6116-6667)
- Aileen Paula Chua
- Pilar Lopez Santi
- Robért Petr
Institutions
- Charles University (CZ)
- Masaryk University (CZ)
- Leiden University Medical Center (NL)
- University Hospital Ostrava (CZ)
- University Hospital Brno (CZ)
- University Hospital Olomouc (CZ)
- Krajská Nemocnice Liberec (CZ)
- Institute of Clinical and Experimental Medicine (CZ)
- Institute of Health Information and Statistics (CZ)
- O2 Czech Republic (Czechia) (CZ)
- University Hospital Kralovske Vinohrady (CZ)
- Liberec Region
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1038/s41598-025-01313-7
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Univerzita Karlova v Praze
- European Commission
- Ministerstvo Zdravotnictví Ceské Republiky